Bryant Lim

Bryant Lim

Director of Finance/CFO at PRELUDE THERAPEUTICS INCORPORATED

Net worth: 26 022 $ as of 2024-03-30

53 year
Health Technology
Consumer Services
Commercial Services

Profile

Bryant D.
Lim
is currently the Director at Life Sciences Pennsylvania since 2019 and the Secretary, Chief Financial & Accounting Officer at Prelude Therapeutics, Inc. since 2023.
Previously, he worked as the Chief Compliance Officer & Vice President at Incyte Corp.
from 2014 to 2018.
He also held positions as Assistant Counsel at Merck & Co., Inc., Associate General Counsel at Viropharma, Inc., and Chief Business Officer, SVP & General Counsel at Aceragen, Inc. from 2022 to 2023.
From 2018 to 2022, he served as the Secretary, Senior VP & General Counsel at Idera Pharmaceuticals, Inc. Mr. Lim completed his undergraduate degree at Rochester Christian University and his graduate degree at Villanova University School of Law.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-07-18 18,217 ( 0.22% ) 14 646 $ 2023-07-30
2024-02-29 2,400 ( 0.00% ) 11 376 $ 2024-03-30

Bryant Lim active positions

CompaniesPositionStart
PRELUDE THERAPEUTICS INCORPORATED Director of Finance/CFO 2024-04-07
Director/Board Member 2019-04-30
All active positions of Bryant Lim

Former positions of Bryant Lim

CompaniesPositionEnd
ACERAGEN, INC. General Counsel 2023-02-16
General Counsel 2022-09-30
INCYTE CORPORATION Compliance Officer 2018-08-31
Viropharma, Inc. Corporate Officer/Principal -
MERCK & CO., INC. General Counsel -
See the detail of Bryant Lim's experience

Training of Bryant Lim

Rochester Christian University Undergraduate Degree
Villanova University School of Law Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Bryant Lim's experience

Connections

95

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
INCYTE CORPORATION

Health Technology

MERCK & CO., INC.

Health Technology

PRELUDE THERAPEUTICS INCORPORATED

Health Technology

Private companies4

Health Technology

Commercial Services

Viropharma, Inc.

Aceragen, Inc.

See company connections